Kenvue, the manufacturer of Tylenol, has replaced its CEO amid an ongoing strategic review. The leadership change has prompted reactions from investors, with the company’s stock showing movement in response to the news.

June’s robust jobs report has effectively dashed hopes for a Federal Reserve rate cut this summer, with strong employment data diminishing the odds for monetary easing.

BYD has sparked a new price war in China’s electric vehicle market by unveiling significant discounts, leading to a sharp decline in its stock price. Several rivals have responded to BYD’s aggressive pricing, intensifying the competitive landscape in the industry.

Shares of Moderna tumbled sharply on Monday after the vaccine maker projected a larger-than-anticipated drop in sales for 2025. The unexpected forecast surprised analysts and investors, signaling potential challenges ahead for the biotech firm.